Uncategorized

Pharmaceutical Competitor Analysis: The Complete Strategic Playbook for IP Teams, R&D Leads, and Institutional Investors

In the fiercely competitive world of pharmaceuticals, staying ahead isn’t just about innovation — it’s about strategic intelligence. As patent cliffs loom and generic competitors threaten market share, how can IP teams, R&D leaders, and institution…

Pharmaceutical Competitor Analysis: The Complete Strategic Playbook for IP Teams, R&D Leads, and Institutional Investors Read Post »

Uncategorized

Why Orange Book Expiration Dates Don’t Match Real Generic Drug Market Entry Dates (and what to use instead)

Why the Orange Book’s Expiration Dates Don’t Match Real-World Generic Market Entry — And What You Should Use Instead
Imagine investing millions into a blockbuster drug only to find out that the generic version hits the market months—or even years—befor…

Why Orange Book Expiration Dates Don’t Match Real Generic Drug Market Entry Dates (and what to use instead) Read Post »

Biotechblog
Scroll to Top